APA (7th ed.) Citation

Bissonnette, R., Haydey, R., Rosoph, L. A., Lynde, C. W., Bukhalo, M., Fowler, J. F., . . . Pariser, D. M. (2018). Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: Results from a double‐blind, placebo‐controlled, randomized study. Journal of the European Academy of Dermatology & Venereology, 32(3), 403. https://doi.org/10.1111/jdv.14647

Chicago Style (17th ed.) Citation

Bissonnette, R., et al. "Apremilast for the Treatment of Moderate‐to‐severe Palmoplantar Psoriasis: Results from a Double‐blind, Placebo‐controlled, Randomized Study." Journal of the European Academy of Dermatology & Venereology 32, no. 3 (2018): 403. https://doi.org/10.1111/jdv.14647.

MLA (9th ed.) Citation

Bissonnette, R., et al. "Apremilast for the Treatment of Moderate‐to‐severe Palmoplantar Psoriasis: Results from a Double‐blind, Placebo‐controlled, Randomized Study." Journal of the European Academy of Dermatology & Venereology, vol. 32, no. 3, 2018, p. 403, https://doi.org/10.1111/jdv.14647.